Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins

Oncogene

Volumn 23, Issue 20, 2004, Pages 3501-3508

  Koziczak, Magdalena ^a   Holbro, Thomas ^a   Hynes, Nancy E ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

Breast cancer; Cyclin D; FGFR; Tyrosine kinase inhibitor

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE 4; FIBROBLAST GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PD 173074; PD 173076; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RETINOBLASTOMA PROTEIN; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHOSPHORYLATION; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL PROLIFERATION; DOWN REGULATION; DRUG SELECTIVITY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL DIVISION; CYCLINS; DOWN-REGULATION; FEMALE; G1 PHASE; HUMANS; PHOSPHORYLATION; PYRIMIDINES; RECEPTORS, FIBROBLAST GROWTH FACTOR; S PHASE; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

UNIDENTIFIED RETROVIRUS;

EID: 2442675495     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207331     Document Type: Article

References (51)

1. Adnane J, Gaudray P, Dionne CA, Crumley G, Jaye M, Schlessinger J, Jeanteur P, Birnbaum D and Theillet C. (1991). Oncogene, 6, 659-663.
2. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A and Pestell RG. (1995). J. Biol. Chem., 270, 23589-23597.
3. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M and Bartek J. (1994). Int. J. Cancer, 57, 353-361.
4. Basilico C and Moscatelli D. (1992). Adv. Cancer Res., 59, 115-165.
5. Boilly B, Vercoutter-Edouart AS, Hondermarck H, Nurcombe V and Le B. (2000). Cytokine Growth Factor Rev., 11, 295-302.
6. Chodosh LA, Gardner HP, Rajan JV, Stairs DB, Marquis ST and Leder PA. (2000). Dev. Biol., 219, 259-276.
7. Connell-Crowley L, Harper JW and Goodrich DW. (1997). Mol. Biol. Cell, 8, 287-301.
8. Cross MJ and Claesson-Welsh L. (2001). Trends Pharmacol. Sci., 22, 201-207.
9. Cross MJ, Hodgkin MN, Roberts S, Landgren E, Wakelam MJ and Claesson-Welsh L. (2000). J. Cell Sci., 113 (Part 4), 643-651.
10. Cuny M, Kramar A, Courjal F, Johannsdottir V, Iacopetta B, Fontaine H, Grenier J, Culine S and Theillet C. (2000). Cancer Res., 60, 1077-1083.
11. Daksis JI, Lu RY, Facchini LM, Marhin WW and Penn LJ. (1994). Oncogene, 9, 3635-3645.
12. Dickson C, Fantl V, Gillett C, Brookes S, Bartek J, Smith R, Fisher C, Barnes D and Peters G. (1995). Cancer Lett., 90, 43-50.
13. Diehl JA, Cheng M, Roussel MF and Sherr CJ. (1998). Genes Dev., 12, 3499-3511.
14. Ethier SP, Mahacek ML, Gullick WJ, Frank TS and Weber BL. (1993). Cancer Res., 53, 627-635.
15. Gerwins P, Skoldenberg E and Claesson-Welsh L. (2000). Crit. Rev. Oncol. Hematol., 34, 185-194.
16. Giri D, Ropiquet F and Ittmann M. (1999). Clin. Cancer Res., 5, 1063-1071.
17. Guttridge DC, Albanese C, Reuther JY, Pestell RG and Baldwin Jr AS. (1999). Mol. Cell. Biol., 19, 5785-5799.
18. Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas III CF and Hynes NE. (2003). Proc. Natl. Acad. Sci. USA, 100, 8933-8938.
19. Hosokawa Y and Arnold A. (1998). Genes Chromosomes Cancer, 22, 66-71.
20. Jaakkola S, Salmikangas P, Nylund S, Partanen J, Armstrong E, Pyrhonen S, Lehtovirta P and Nevanlinna H. (1993). Int. J. Cancer, 54, 378-382.
21. Jang JH, Shin KH and Park JG. (2001). Cancer Res., 61, 3541-3543.
22. Kim I, Moon S, Yu K, Kim U and Koh GY. (2001). Biochim. Biophys. Acta, 1518, 152-156.
23. Klint P and Claesson-Welsh L. (1999). Front. Biosci., 4, D165-D177.
24. Kornmann M, Ishiwata T, Beger HG and Korc M. (1997). Oncogene, 15, 1417-1424.
25. Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I and Schlessinger J. (1997). Cell, 89, 693-702.
26. Koziczak M, Krek W and Nagamine Y. (2000). Mol. Cell. Biol., 20, 2014-2022.
27. Lane HA, Beuvink I, Motoyama AB, Daly JM, Neve RM and Hynes NE. (2000). Mol. Cell. Biol., 20, 3210-3223.
28. Lavia P and Jansen-Durr P. (1999). BioEssays, 21, 221-230.
29. Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P and Rosen N. (1994). Oncogene, 9, 1925-1929.
30. Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J, Pestell RG and Kanakura Y. (1999). EMBO J., 18, 1367-1377.
31. Mohammadi M, Froum S, Hamby JM, Schroeder MC, Panek RL, Lu GH, Eliseenkova AV, Green D, Schlessinger J and Hubbard SR. (1998). EMBO J., 17, 5896-5904.
32. Morgan DO. (1995). Nature, 374, 131-134.
33. Nagata D, Suzuki E, Nishimatsu H, Satonaka H, Goto A, Omata M and Hirata Y. (2001). J. Biol. Chem., 276, 662-669.
34. Neve RM, Holbro T and Hynes NE. (2002). Oncogene, 21, 4567-4576.
35. Neve RM, Sutterluty H, Pullen N, Lane HA, Daly JM, Krek W and Hynes NE. (2000). Oncogene, 19, 1647-1656.
36. Ong SH, Guy GR, Hadari YR, Laks S, Gotoh N, Schlessinger J and Lax I. (2000). Mol. Cell. Biol., 20, 979-989.
37. Ong SH, Hadari YR, Gotoh N, Guy GR, Schlessinger J and Lax I. (2001). Proc. Natl. Acad. Sci. USA, 98, 6074-6079.
38. Ornitz DM and Itoh N. (2001). Genome Biol., 2, REVIEWS3005.
39. Penault-Llorca F, Bertucci F, Adelaide J, Parc P, Coulier F, Jacquemier J, Birnbaum D and deLapeyriere O. (1995). Int. J. Cancer, 61, 170-176.
40. Plotnikov AN, Hubbard SR, Schlessinger J and Mohammadi M. (2000). Cell, 101, 413-424.
41. Rimokh R, Berger F, Bastard C, Klein B, French M, Archimbaud E, Rouault JP, Santa LB, Duret L and Vuillaume M. (1994). Blood, 83, 3689-3696.
42. Sherr CJ. (1996). Science, 274, 1672-1677.
43. Sherr CJ and Roberts JM. (1999). Genes Dev., 13, 1501-1512.
44. Suyama K, Shapiro I, Guttman M and Hazan RB. (2002). Cancer Cell, 2, 301-314.
45. Tetsu O and McCormick F. (1999). Nature, 398, 422-426.
46. Theillet C, Adelaide J, Louason G, Bonnet-Dorion F, Jacquemier J, Adnane J, Longy M, Katsaros D, Sismondi P and Gaudray P. (1993). Genes Chromosomes Cancer, 7, 219-226.
47. Valve E, Martikainen P, Seppanen J, Oksjoki S, Hinkka S, Anttila L, Grenman S, Klemi P and Harkonen P. (2000). Int. J. Cancer, 88, 718-725.
48. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A and Schmidt EV. (1994). Nature, 369, 669-671.
49. Werner S, Smola H, Liao X, Longaker MT, Krieg T, Hofschneider PH and Williams LT. (1994). Science, 266, 819-822.
50. Yamaguchi F, Saya H, Bruner JM and Morrison RS. (1994). Proc. Natl. Acad. Sci. USA, 91, 484-488.
51. Yayon A, Ma YS, Safran M, Klagsbrun M and Halaban R. (1997). Oncogene, 14, 2999-3009.